Zapping the brain during sleep may tweak rhythms tied to schizophrenia

NCT ID NCT07680114

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether a non-invasive electrical brain stimulation technique called TES-TI can temporarily alter sleep spindles—brain rhythms often reduced in schizophrenia. Researchers will apply the stimulation during sleep in 20 people (half with schizophrenia spectrum disorders, half healthy controls) over two overnight lab visits. The goal is to see if targeting the thalamus can boost spindle activity, which may help understand the brain's role in the condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcranial electrical stimulation with temporal interference (TES-TI)

What this could lead to

If this works, it could point toward a new way to improve sleep-related brain activity in people with schizophrenia, potentially aiding symptom management.

What could go wrong

This is a very small, early feasibility study with only 20 participants. It tests a temporary effect during one night, so any changes may not last or translate into real-world benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Wisconsin

    Madison, Wisconsin, 53719, United States